Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-29

Clinical Trial Update: Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression [NA]

View source ↗

Summary

Clinical trial update on transcutaneous vagal nerve stimulation aiming to modulate stress response in major depressive disorder; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous vagal nerve stimulation (tVNS) (transcutaneous vagal nerve stimulation)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | NA | Status: ACTIVE_NOT_RECRUITING